Comparing with normal tissues, CFP is highly expressed in kidney cancer, leukemia, and lymphoma, while being significantly decreased in bladder cancer, brain cancer, and central nervous system cancer, breast cancer, colorectal cancer, leukemia, liver cancer, lung cancer, myeloma, ovarian cancer, and sarcoma (Figure 1A). The gene discussed is CFP; the disease is plasma cell myeloma.